ロード中...

A novel fully human antitumour immunoRNase targeting ErbB2-positive tumours

BACKGROUND: ErbB2 is an attractive target for immunotherapy, as it is a tyrosine kinase receptor overexpressed on tumour cells of different origin, with a key role in the development of malignancy. Trastuzumab, the only humanised anti-ErbB2 antibody currently used in breast cancer with success, can...

詳細記述

保存先:
書誌詳細
主要な著者: Borriello, M, Laccetti, P, Terrazzano, G, D'Alessio, G, De Lorenzo, C
フォーマット: Artigo
言語:Inglês
出版事項: Nature Publishing Group 2011
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3111160/
https://ncbi.nlm.nih.gov/pubmed/21559015
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2011.146
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!